• Main
  • Useful links
  • Information for Contributors
  • About
  • Editorial board

    •
    Bulletin of problems biology and medicine / Issue 4 (167), 2022 / PERFECT BIOPSY METHODS FOR THE DIAGNOSIS OF MALIGNANT MELANOCYTIC SKIN NEOPLASMS (A LITERATURE REVIEW)

    Fomina L. V., Aslanyan S. A., Gumeniuk K. V., Fomin O. O., Trutyak I.R.

    PERFECT BIOPSY METHODS FOR THE DIAGNOSIS OF MALIGNANT MELANOCYTIC SKIN NEOPLASMS (A LITERATURE REVIEW)

    About the author:

    Fomina L. V., Aslanyan S. A., Gumeniuk K. V., Fomin O. O., Trutyak I.R.

    Heading:

    LITERATURE REVIEWS

    Type of article:

    Scentific article

    Annotation:

    Skin biopsy has long been the main method of diagnosing malignant skin neoplasms, particularly melanoma. The modern scientific research is devoted to the actual problem of the clinical dermato-oncology – the search for the most optimal methods of morphological verification of the malignant skin tumors. The problem of the determining safe and effective melanoma biopsy methods in the context of the evidence-based medicine remains particularly relevant. The most popular methods today are excisional and incisional biopsy, shave biopsy and punch biopsy. The most guidelines recommend full-thickness excisional biopsy as the preferred procedure for suspected melanoma, but there are increasing cases where excisional biopsy is not possible. There is currently no consensus on the best technique for skin biopsy in the diagnosis of melanoma. Most publications concluded that misdiagnosis of sufficient depth and thickness of melanoma is likely to lead to inadequate therapy, but the main danger lies in misdiagnosis. Excisional biopsy remains the best and most reliable way to obtain information about skin lesions. The advantage in the choice of the method, in the presence of neoplasms in cosmetically sensitive areas or their large size, is inclined to incisional biopsy. Other techniques, such as punch biopsy or shave biopsy, are recognized as more dangerous in terms of diagnostic inaccuracy, but at the same time do not contribute to the spread of the tumor. The experience of doctors and the choice of medical institution did not have any influence on the choice of methodology and the quality of diagnosis, however, timely consultation of a dermatologist proved to be more rational for timely diagnosis and further treatment. The correct choice of the biopsy method, its technique (depth and edges of excision) for the diagnosis of malignant neoplasms of the skin require further clarification.

    Tags:

    : skin biopsy,nevus,melanocytic skin neoplasms,malignant neoplasms of the skin,melanoma,technique,complications,dermato-oncology

    Bibliography:

    1. Ramsey ML, Rostami S. Skin Biopsy. Treasure Island (FL): StatPearls Publishing; 2022.
    2. Greenwood JD, Merry SP, Boswell CL. Skin Biopsy Techniques. Prim Care. 2022;49(1):1-22. DOI: 10.1016/j.pop.2021.10.001. 
    3. Messina JL, Gibbs J. Pathologic analysis of melanocytic neoplasms. Semin Cutan Med Surg. 2018;37(2):88-100. DOI: 10.12788/j. sder.2017.054. 
    4. Phillips M, Marsden H, Jaffe W, Matin RN, Wali GN, Greenhalgh J, et al. Assessment of Accuracy of an Artificial Intelligence Algorithm to Detect Melanoma in Images of Skin Lesions. JAMA network open. 2019;2(10):e1913436. DOI: https://doi.org/10.1001/jamanetworkopen.2019. 13436.
    5. Navarrete-Dechent C, Cordova M, Sahu A, Liopyris A, Rishpon A, Chen C, et al. Optical imaging guided- ‘precision’ biopsy of skin tumors: a novel approach for targeted sampling and histopathologic correlation. Arch Dermatol Res. 2021;313(7):517-529. DOI: 10.1007/s00403- 020-02126-6.
    6. Chuchu N, Dinnes J, Takwoingi Y, Matin RN, Bayliss SE, Davenport CE, et al. Teledermatology for diagnosing skin cancer in adults. Cochrane Database Syst Rev. 2018;12(12):CD013193. DOI: 10.1002/14651858.CD013193.
    7. Kilic A, Kilic A, Kivanc AE, Sisik A. Biopsy Techniques for Skin Disease and Skin Cancer: A New Approach. J Cutan Aesthet Surg. 2020;13(3):251-254. DOI: 10.4103/JCAS.JCAS_173_19.
    8. Knackstedt T, Knackstedt RW, Couto R, Gastman B. Malignant Melanoma: Diagnostic and Management Update. Plast Reconstr Surg. 2018;142(2):202e-216e. DOI: 10.1097/PRS.0000000000004571. 
    9. Davis LE, Shalin SC, Tackett AJ. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20(11):1366-1379. DOI: 10.1080/15384047.2019.1640032.
    10. Beard CJ, Ponnarasu S, Schmieder GJ. Excisional Biopsy. Treasure Island (FL): StatPearls Publishing; 2021.
    11. Naik PP. Cutaneous Malignant Melanoma: A Review of Early Diagnosis and Management. World J Oncol. 2021;12(1):7-19. DOI: 10.14740/ wjon1349.
    12. Hartman RI, Lin JY. Cutaneous Melanoma-A Review in Detection, Staging, and Management. Hematol Oncol Clin North Am. 2019;33(1):25- 38. DOI: 10.1016/j.hoc.2018.09.005.
    13. Dorrell DN, Strowd LC. Skin Cancer Detection Technology. Dermatol Clin. 2019;37(4):527-536. DOI: 10.1016/j.det.2019.05.010.
    14. Chopra A, Sharma R, Rao UNM. Pathology of Melanoma. Surg Clin North Am. 2020;100(1):43-59. DOI: 10.1016/j.suc.2019.09.004.
    15. Tadiparthi S, Panchani S, Iqbal A. Biopsy for malignant melanoma--are we following the guidelines? Ann R Coll Surg Engl. 2008;90(4):322- 325. DOI: 10.1308/003588408X285856.
    16. NICE 2022. Melanoma: assessment and management. NICE; 2022. Available from: https://www.nice.org.uk/terms-andconditions#noticeof-rights.
    17. de Menezes SL, Wolfe R, Kelly JW, Farrugia H, Mar VJ. Think before you shave: Factors influencing choice of biopsy technique for invasive melanoma and effect on definitive management. Australas J Dermatol. 2020;61(2):134-139. DOI: 10.1111/ajd.13227.
    18. Shellenberger RA, Fayyaz F, Sako Z, Schaeffer M, Tawagi K, Scheidel C, et al. Impact of Biopsy Technique on Clinically Important Outcomes for Cutaneous Melanoma: A Systematic Review and Meta-analysis. Mayo Clin Proc Innov Qual Outcomes. 2020;4(4):373-383. DOI: 10.1016/j. mayocpiqo.2020.04.005.
    19. Ahmadi O, Das M, Hajarizadeh B, Mathy JA. Impact of Shave Biopsy on Diagnosis and Management of Cutaneous Melanoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2021;28(11):6168-6176. DOI: 10.1245/s10434-021-09866-3.
    20. Shao E, Blake T, Po-Chao F, Pool L, Carew B, Yong-Gee S, et al. Prospective study of pigmented lesions managed by shave excision with no deep margin transection of melanomas. Australas J Dermatol. 2020;61(3):269-272. DOI: 10.1111/ajd.13312.
    21. .Etzkorn JR, Sharkey JM, Grunyk JW, Shin TM, Sobanko JF, Miller CJ. Frequency of and risk factors for tumor upstaging after wide local excision of primary cutaneous melanoma. J Am Acad Dermatol. 2017;77(2):341-348. DOI: 10.1016/j.jaad.2017.03.018.
    22. Liszewski W, Stewart JR, Vidal NY, Demer AM. Incisional Biopsy Technique Is Associated With Decreased Overall Survival for Cutaneous Melanoma. Dermatol Surg. 2022;48(5):486-491. DOI: 10.1097/DSS. 0000000000003430.
    23. Ramiscal JAB, Stern SL, Wilson AK, Lorimer PD, Lee NA, Goldfarb MR, et al. Does Residual Invasive Disease in Wide Local Excision after Diagnosis with Partial Biopsy Technique Influence Survival in Melanoma? Matched-Pair Analysis of Multicenter Selective Lymphadenectomy Trial I and II. J Am Coll Surg. 2022;235(1):49-59. DOI: 10.1097/XCS.0000000000000263.
    24. Shao E, Blake T, Po-Chao F, Pool L, Carew B, Yong-Gee S, et al. Prospective study of pigmented lesions managed by shave excision with no deep margin transection of melanomas. Australas J Dermatol. 2020;61(3):269-272. DOI: 10.1111/ajd.13312.
    25. Pitney T, Shao E, Muir J. A Reply to ‘Think before you shave: factors influencing choice of biopsy technique for invasive melanoma and effect on definitive management’. Australas J Dermatol. 2021;62(1):96-97. DOI: 10.1111/ajd.13389.
    26. Kok Y, Scott K, Pham A, Liu W, Roberts H, Pan Y, et al. The impact of incomplete clinical information and initial biopsy technique on the histopathological diagnosis of cutaneous melanoma. Australas J Dermatol. 2021;62(4):e524-e531. DOI: 10.1111/ajd.13697.
    27. Testori AAE, Blankenstein SA, van Akkooi ACJ. Primary Melanoma: from History to Actual Debates. Curr Oncol Rep. 2019;21(12):112. DOI: 10.1007/s11912-019-0843-x.
    28. Moscarella E, Pampena R, Palmiotti G, Bonamonte D, Brancaccio G, Piccolo V, et al. A meta-analysis on the influence of partial biopsy of primary melanoma on disease recurrence and patient survival. J Eur Acad Dermatol Venereol. 2020;34(2):279-284. DOI: 10.1111/ jdv.15903.
    29. Doolan BJ, Robinson AJ, Wolfe R, Kelly JW, McLean C, McCormack C, et al. Accuracy of partial biopsies in the management of cutaneous melanoma. Australas J Dermatol. 2019;60(3):209-213. DOI: 10.1111/ajd.13004.
    30. Kim CC, Berry EG, Marchetti MA, Swetter S, Lim G, Grossman D, et al. Risk of Subsequent Cutaneous Melanoma in Moderately Dysplastic Nevi Excisionally Biopsied but With Positive Histologic Margins. JAMA Dermatol. 2018;154(12):1401-1408. DOI: 10.1001/jamadermatol.2018.3359.
    31. Kok Y, Scott K, Pham A, Liu W, Roberts H, Pan Y, et al. The impact of incomplete clinical information and initial biopsy technique on the histopathological diagnosis of cutaneous melanoma. Australas J Dermatol. 2021;62(4):e524-e531. DOI: 10.1111/ajd.13697.
    32. Menezes SL, Kelly JW, Mar V. The increasing use of shave biopsy for diagnosing invasive melanoma in Australia. Medical Journal of Australia. 2020;212(5):238-238.e1. DOI: 10.5694/mja2.50502.
    33. Ahmadi O, Das M, Hajarizadeh B, Mathy JA. Impact of Shave Biopsy on Diagnosis and Management of Cutaneous Melanoma: A Systematic Review and Meta-Analysis. Ann Surg Oncol. 2021;28(11):6168-6176. DOI: 10.1245/s10434-021-09866-3.
    34. Pitney T, Muir DJ. Single-center, single-operator, retrospective analysis of base transection rates in shave procedures for melanoma diagnosis. J Am Acad Dermatol. 2021;84(3):861-862. DOI: 10.1016/j.jaad.2020.10.049.
    35. Breslavets M, Lapa T. The tangential punch biopsy. Dermatol Online J. 2019;25(12):13030/qt1g60q188.
    36. Navarrete-Dechent C, Cordova M, Sahu A, Liopyris K, Rishpon A, Chen C, et al. Optical imaging guided- ‘precision’ biopsy of skin tumors: a novel approach for targeted sampling and histopathologic correlation. Arch Dermatol Res. 2021;313(7):517-529. DOI: 10.1007/s00403- 020-02126-6.
    37. Nelson DW, Stern S, Elashoff DE, Elashoff R, Thompson J, Mozzillo N, et al. Impact of Time Between Diagnosis and SLNB on Outcomes in Cutaneous Melanoma. J Am Coll Surg. 2017;225(2):302-311. DOI: 10.1016/j. jamcollsurg.2017.05.013.
    38. Lau KL, Bradish T, Rannan-Eliya S. ‘Primum non nocere’: how harmless is routine wide local excision for AJCC stage IA melanoma? Ann R Coll Surg Engl. 2020;102(7):483-487. DOI: 10.1308/rcsann.2020.0050.
    39. Huayllani MT, Bagaria SP, Restrepo DJ, Boczar D, Sisti A, Cochuyt JJ, et al. Wide Excisional Surgery in Invasive Melanoma Treatment: Factors Driving Non-compliance With National Guidelines. Anticancer Res. 2020;40(2):1065-1069. DOI: 10.21873/anticanres.14044.
    40. Brian T, Jameson MB. Skin lesions suspicious for melanoma: New Zealand excision margin guidelines in practice. J Prim Health Care. 2018;10(3):210-214. DOI: 10.1071/HC17055.
    41. Chernyshov PV, Lallas A, Tomas-Aragones L, Arenbergerova M, Samimi M, Manolache L, et al. Quality of life measurement in skin cancer patients: literature review and position paper of the European Academy of Dermatology and Venereology Task Forces on Quality of Life and Patient Oriented Outcomes, Melanoma and Non-Melanoma Skin Cancer. J Eur Acad Dermatol Venereol. 2019;33(5):816-827. DOI: 10.1111/jdv.15487.
    42. Garbe C, Peris K, Soura E, Forsea AM, Hauschild A, Arenbergerova M, et al. The evolving field of Dermato-oncology and the role of dermatologists: Position Paper of the EADO, EADV and Task Forces, EDF, IDS, EBDV-UEMS and EORTC Cutaneous Lymphoma Task Force. J Eur Acad Dermatol Venereol. 2020;34(10):2183-2197. DOI: 10.1111/jdv.16849.
    43. Restrepo DJ, Huayllani MT, Boczar D, Sisti A, Gabriel E, Lemini R, et al. Biopsy Type Disparities in Patients With Melanoma: Who Receives the Standard of Care? Anticancer Res. 2019;39(11):6359-6363. DOI: 10.21873/anticanres.13848.
    44. Garbe C, Amaral T, Peris K, Hauschild A, Arenberger P, Basset-Seguin N, et al. European consensus-based interdisciplinary guideline for melanoma. Part 2: Treatment – Update 2022. Eur J Cancer. 2022;170:256-284. DOI: 10.1016/j.ejca.2022.04.018.
    45. Nenclares P, Ap Dafydd D, Bagwan I, Miao B, Lu Y, Chen T. Head and neck mucosal melanoma: The United Kingdom national guidelines. Eur J Cancer. 2020;138:11-18. DOI: 10.1016/j.ejca.2020.07.017.
    46. Murchie P, Amalraj Raja E, Brewster DH, Iversen L, Lee AJ. Is initial excision of cutaneous melanoma by General Practitioners (GPs) dangerous? Comparing patient outcomes following excision of melanoma by GPs or in hospital using national datasets and meta-analysis. Eur J Cancer. 2017;86:373-384. DOI: 10.1016/j.ejca.2017.09.034.
    47. Dougher MC, Butt M, Helm KF, Helm MF. Impact of trainee experience on shave biopsy specimen size [published online ahead of print, 2022 May 14]. Int J Dermatol. 2022. DOI: 10.1111/ijd.16212.
    48. Voloshynovych M, Blaga I, Girnyk GY, Holotiuk V, Kаlmykova A. Melanoma shkiry: vid mayzhe nevydymoyi do vizualʹno nezaperechnoyi. Okremi pryntsypy kerivnytstva ta ohlyad klinichnykh vypadkiv. Ukr. Med. Chasopys. 2020;3(137):1-5. DOI: 10.32471/umj.1680- 3051.137.179285. [in Ukrainian].
    49. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology: Melanoma, Version 3.2022. NCCN; 2022. Available from: https://www.nccn.org/professionals/physician_gls/pdf/cutaneous_me lanoma.pdf.

    Publication of the article:

    «Bulletin of problems biology and medicine» Issue 4 (167), 2022 year, 92-98 pages, index UDK 616.5–006-072-08

    DOI:

    10.29254/2077-4214-2022-4-167-92-98